{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:27:17Z","timestamp":1771626437254,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s11906-003-0068-z","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T01:56:02Z","timestamp":1180058162000},"page":"122-125","source":"Crossref","is-referenced-by-count":18,"title":["Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease"],"prefix":"10.1007","volume":"5","author":[{"given":"Emmanuel L.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"68_CR1","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","volume":"96","author":"SY Chen","year":"1999","unstructured":"Chen SY, Bhargava A, Mastroberardino L, et al.: Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci U S A 1999, 96:2514\u20132519.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"68_CR2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/endo.142.4.8095","volume":"142","author":"A Chargava","year":"2001","unstructured":"Chargava A, Fullerton MJ, Myles K et al.: The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology 2001, 142:1587\u20131594.","journal-title":"Endocrinology"},{"key":"68_CR3","doi-asserted-by":"crossref","first-page":"I207","DOI":"10.1161\/01.HYP.11.2_Pt_2.I207","volume":"11","author":"EL Bravo","year":"1988","unstructured":"Bravo EL, Fouad-Tarazi FM, Tarazi RC, et al.: Clinical implications of primary aldosteronism with resistant hypertension. Hypertension 1988, 11:I207\u2013211.","journal-title":"Hypertension"},{"key":"68_CR4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.48.3.491","volume":"48","author":"EL Bravo","year":"1973","unstructured":"Bravo EL, Dustan HP, Tarazi RC: Spironolactone as a nonspecific treatment of primary aldosteronism. Circulation 1973, 48:491\u2013498.","journal-title":"Circulation"},{"key":"68_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","volume":"131","author":"RP Ghose","year":"1999","unstructured":"Ghose RP, Hall PM, Bravo EL: Medical management of aldosterone-producing adenomas. Ann Intern Med 1999, 131:105\u2013108.","journal-title":"Ann Intern Med"},{"key":"68_CR6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"Weinberger MH, Roniker B, Krause SL, Weiss RJ: Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 2002, 15:709\u2013716. This study demonstrated that eplerenone is efficacious in the treatment of mild to moderate hypertension.","journal-title":"Am J Hypertens"},{"issue":"4","key":"68_CR7","doi-asserted-by":"crossref","first-page":"OR55","DOI":"10.1016\/S0895-7061(02)02261-6","volume":"15","author":"M Weinberger","year":"2002","unstructured":"Weinberger M, MacDonald T, Conlin PR, et al.: Comparison of eplerenone and losartan in patients with low-renin hypertension [abstract]. Am J Hypertens 2002, 15(4 Pt 2):OR55.","journal-title":"Am J Hypertens"},{"key":"68_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.HYP.29.1.45","volume":"29","author":"Y Takeda","year":"1997","unstructured":"Takeda Y, Miyamori I, Inaba S, et al.: Vascular aldosterone in genetically hypertensive rats. Hypertension 1997, 29:45\u201348.","journal-title":"Hypertension"},{"key":"68_CR9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.HYP.36.4.495","volume":"36","author":"Y Takeda","year":"2000","unstructured":"Takeda Y, Yoneda T, Demura M, et al.: Cardiac aldosterone production in genetically hypertensive rats. Hypertension 2000, 36:495\u2013500.","journal-title":"Hypertension"},{"key":"68_CR10","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/endo.138.8.5326","volume":"138","author":"CE Gomez-Sanchez","year":"1997","unstructured":"Gomez-Sanchez CE, Zhou MY, Cozza EN, et al.: Aldosterone biosynthesis in the rat brain. Endocrinology 1997, 138:3369\u20133373.","journal-title":"Endocrinology"},{"key":"68_CR11","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","volume":"273","author":"JS Silvestre","year":"1998","unstructured":"Silvestre JS, Robert V, Heymes C, et al.: Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998, 273:4883\u20134891.","journal-title":"J Biol Chem"},{"key":"68_CR12","doi-asserted-by":"crossref","first-page":"III7","DOI":"10.1161\/01.HYP.18.5_Suppl.III7","volume":"18","author":"MJ Brody","year":"1991","unstructured":"Brody MJ, Varner KJ, Vasquez EC, Lewis SJ: Central nervous system and the pathogenesis of hypertension. Sites and mechanisms. Hypertension 1991, 18:III7-II12.","journal-title":"Hypertension"},{"key":"68_CR13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1006\/frne.1997.0157","volume":"18","author":"EP Gomez-Sanchez","year":"1997","unstructured":"Gomez-Sanchez EP: Central hypertensive effects of aldosterone. Front Neuroendocrinol 1997, 18:440\u2013462.","journal-title":"Front Neuroendocrinol"},{"key":"68_CR14","first-page":"E649","volume":"258","author":"EP Gomez-Sanchez","year":"1990","unstructured":"Gomez-Sanchez EP, Venkataraman MT, Thwaites D, Fort C: ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 1990, 258:E649-E653.","journal-title":"Am J Physiol"},{"key":"68_CR15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/26.7.671","volume":"26","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT: Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovas Res 1992, 26:671\u2013677.","journal-title":"Cardiovas Res"},{"key":"68_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","volume":"25","author":"CG Brilla","year":"1993","unstructured":"Brilla CG, Matsubara LS, Weber KT: Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993, 25:563\u2013575.","journal-title":"J Mol Cell Cardiol"},{"key":"68_CR17","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","volume":"141","author":"R Rocha","year":"2000","unstructured":"Rocha R, Stier CT Jr, Kifor I, et al.: Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000, 141:3871\u20133878.","journal-title":"Endocrinology"},{"key":"68_CR18","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","volume":"283","author":"R Rocha","year":"2002","unstructured":"Rocha R, Rudolph AE, Frierdich GE, et al.: Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 2002, 283:H1802-H1810. In this study, uninephrectomized rats receiving a high-salt diet and aldosterone developed severe hypertension after 2 weeks of treatment.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"68_CR19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","volume":"33","author":"R Rocha","year":"1999","unstructured":"Rocha R, Chander PN, Zuckerman A, Stier CT Jr: Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 1999, 33:232\u2013237.","journal-title":"Hypertension"},{"issue":"1","key":"68_CR20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","volume":"31","author":"R Rocha","year":"1998","unstructured":"Rocha R, Chander PN, Khanna K, et al.: Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998, 31(1 Pt2):451\u2013458.","journal-title":"Hypertension"},{"key":"68_CR21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709\u2013717. A clinical study providing support for the role of aldosterone in cardiac pathophysiology.","journal-title":"N Engl J Med"},{"key":"68_CR22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","volume":"35","author":"RJ MacFadyen","year":"1997","unstructured":"MacFadyen RJ, Barr CS, Struthers AD: Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 1997, 35:30\u201334.","journal-title":"Cardiovasc Res"},{"key":"68_CR23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","volume":"101","author":"CA Farquharson","year":"2000","unstructured":"Farquharson CA, Struthers AD: Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure. Circulation 2000, 101:594\u2013597.","journal-title":"Circulation"},{"key":"68_CR24","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","volume":"95","author":"GP Rossi","year":"1997","unstructured":"Rossi GP, Sacchetto A, van E, et al.: Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma. Circulation 1997, 95:1471\u20131478.","journal-title":"Circulation"},{"key":"68_CR25","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","volume":"82","author":"K Swedberg","year":"1990","unstructured":"Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990, 82:1730\u20131736.","journal-title":"Circulation"},{"key":"68_CR26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","volume":"76","author":"CS Barr","year":"1995","unstructured":"Barr CS, Lang CC, Hanson J, et al.: Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995, 76:1259\u20131265.","journal-title":"Am J Cardiol"},{"key":"68_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(96)80009-1","volume":"2","author":"AD Struthers","year":"1996","unstructured":"Struthers AD: Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart filature. J Cardiac Fail 1996, 2:47\u201354.","journal-title":"J Cardiac Fail"},{"key":"68_CR28","first-page":"1452A","volume":"96","author":"S Yusuf","year":"1997","unstructured":"Yusuf S: Untitled abstract. Circulation 1997, 96:1452A.","journal-title":"Circulation"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-003-0068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-003-0068-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-003-0068-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:16:06Z","timestamp":1559434566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-003-0068-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s11906-003-0068-z","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}